| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35115-10ug | |||
| Carrier-Free | NBP2-35115-1mg | |||
| Carrier-Free | NBP2-35115-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34901-1mg | |||
| Carrier-Free | NBP2-34901-100ug | |||
| Carrier-Free | NBP2-34901-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74348 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35293-1mg | |||
| Carrier-Free | NBP2-35293-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35000-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35296-1mg | |||
| Carrier-Free | NBP2-35296-100ug | |||
| Carrier-Free | NBP2-35296-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34902-1mg | |||
| Carrier-Free | NBP2-34902-100ug | |||
| Carrier-Free | NBP2-34902-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35253-1mg | |||
| Carrier-Free | NBP2-35253-100ug | |||
| Carrier-Free | NBP2-35253-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35132-1mg | |||
| Carrier-Free | NBP2-35132-100ug | |||
| Carrier-Free | NBP2-35132-500ug | |||
![SDS-Page: Human Oncostatin M/OSM 195 a.a Protein [NBP2-35115]](http://images.novusbio.com/fullsize/Human-Oncostatin-M-OSM-195-a.a-Protein-SDS-Page-NBP2-35115-img0001.jpg "SDS-Page: Human Oncostatin M/OSM 195 a.a Protein [NBP2-35115]")
![In vitro assay: TNFSF4 Protein [NBP2-26577] - Demonstration in vitro of the potency of Fc-OX40L in comparison to an agonist antibody OX86, with anti-CD3 alone serving as a negative control for co-stimulation.](http://images.novusbio.com/fullsize/TNFSF4-Protein-In-vitro-assay-NBP2-26577-img0001.jpg "In vitro assay: TNFSF4 Protein [NBP2-26577] - Demonstration in vitro of the potency of Fc-OX40L in comparison to an agonist antibody OX86, with anti-CD3 alone serving as a negative control for co-stimulation.")
![SDS-Page: TNFSF4 Protein [NBP2-26577] - Electrophoretic analysis of Fc-mOX40L using Coomassie blue stained 4-20% reducing SDS-PAGE.](http://images.novusbio.com/fullsize/TNFSF4-Protein-SDS-Page-NBP2-26577-img0002.jpg)
![SDS-Page: Recombinant Mouse OX40 Ligand/TNFSF4 Protein [NBP2-26577] - Electrophoretic analysis of Fc-mOX40L using Coomassie blue stained 4-15% reducing SDS-PAGE.](http://images.novusbio.com/fullsize/Recombinant-Mouse-OX40-Ligand-TNFSF4-Protein-SDS-Page-NBP2-26577-img0004.jpg)
![SDS-Page: Human IL-6 Protein [NBP2-34901]](http://images.novusbio.com/fullsize/Human-IL-6-Protein-SDS-Page-NBP2-34901-img0001.jpg "SDS-Page: Human IL-6 Protein [NBP2-34901]")
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0006.jpg "Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)")
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0001.jpg)
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0002.jpg)
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0003.jpg)
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0004.jpg)
![Immunohistochemistry: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-Immunohistochemistry-NBP2-45466-img0005.jpg)
![SDS-Page: SPT3 Antibody (OTI1A5) [NBP2-45466] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPT3.](http://images.novusbio.com/fullsize/SPT3-Antibody-OTI1A5-SDS-Page-NBP2-45466-img0008.jpg)
![SDS-Page: Rat EGF Protein [NBP2-35293]](http://images.novusbio.com/fullsize/Rat-EGF-Protein-SDS-Page-NBP2-35293-img0001.jpg "SDS-Page: Rat EGF Protein [NBP2-35293]")
![SDS-Page: Human IGF-I Protein [NBP2-35000]](http://images.novusbio.com/fullsize/Human-IGF-I-Protein-SDS-Page-NBP2-35000-img0001.jpg "SDS-Page: Human IGF-I Protein [NBP2-35000]")
![SDS-Page: Recombinant Human c-Myc Protein [H00004609-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.](http://images.novusbio.com/fullsize/Recombinant-Human-c-Myc-Protein-SDS-Page-H00004609-P01-img0002.jpg "SDS-Page: Recombinant Human c-Myc Protein [H00004609-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.")
![SDS-Page: Rat FGF18 Protein [NBP2-35296]](http://images.novusbio.com/fullsize/Rat-FGF18-Protein-SDS-Page-NBP2-35296-img0001.jpg "SDS-Page: Rat FGF18 Protein [NBP2-35296]")
![SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa](http://images.novusbio.com/fullsize/Human-IL-7-Protein-SDS-Page-NBP2-34902-img0001.jpg "SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa")
![SDS-Page: Rat IL-5 Protein [NBP2-35253]](http://images.novusbio.com/fullsize/Rat-IL-5-Protein-SDS-Page-NBP2-35253-img0002.jpg "SDS-Page: Rat IL-5 Protein [NBP2-35253]")
![HPLC: Recombinant Rat IL-5 Protein [NBP2-35253] - Rat IL5 Protein [NBP2-35253]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-5-Protein-HPLC-NBP2-35253-img0003.jpg)
![SDS-Page: Mouse IL-5 Protein [NBP2-35132]](http://images.novusbio.com/fullsize/Mouse-IL-5-Protein-SDS-Page-NBP2-35132-img0001.jpg "SDS-Page: Mouse IL-5 Protein [NBP2-35132]")
![HPLC: Recombinant Mouse IL-5 Protein [NBP2-35132]](http://images.novusbio.com/fullsize/Recombinant-Mouse-IL-5-Protein-HPLC-NBP2-35132-img0002.jpg)
![SDS-Page: Recombinant Human IGF-I/IGF-1 Protein [NBP2-34947]](http://images.novusbio.com/fullsize/Human-DES1-3-IGF-1-Protein-SDS-Page-NBP2-34947-img0001.jpg "SDS-Page: Recombinant Human IGF-I/IGF-1 Protein [NBP2-34947]")